X-Energy (XE) Registration filing summary
Event summary combining transcript, slides, and related documents.
Registration filing summary
3 Apr, 2026Company overview and business model
Designs advanced small modular nuclear reactors (SMRs) and manufactures proprietary TRISO-X nuclear fuel, targeting growing global electricity demand, especially from AI and data centers.
Flagship product, Xe-100, is a high-temperature gas-cooled reactor (HTGR) designed for modular deployment, high reliability, and intrinsic safety, with a four-reactor plant configuration delivering 320 MWe.
Business model is IP-driven, generating revenue from technology licensing, project services, and recurring fuel fabrication, without owning or operating plants.
Initial customers include Dow, Amazon, and Centrica, underpinning a pipeline of over 11 GWe and 144 reactors across the U.S. and U.K.
TRISO-X fuel is produced at a dedicated facility in Oak Ridge, TN, with plans for expansion to meet future reactor deployments.
Financial performance and metrics
For the year ended December 31, 2025, reported $109.1M in total revenues and grant income, with $94.3M from services and $14.8M from grants.
Operating loss for 2025 was $170.3M, with a net loss of $389.8M, reflecting high R&D and SG&A expenses as the company scales.
Cash and cash equivalents at year-end 2025 were $458.9M, with total assets of $1.2B and total mezzanine equity of $2.07B.
Financing activities in 2025 provided $726.1M, primarily from preferred equity issuances.
Company expects continued operating losses and negative cash flows as it invests in technology and project development.
Use of proceeds and capital allocation
Net proceeds from the IPO will be used to purchase newly issued Common Units from XERC, the operating subsidiary.
XERC will use proceeds for working capital, R&D, sales and marketing, general corporate purposes, and capital expenditures, including supply chain and procurement.
A portion may be allocated to future growth projects.
Latest events from X-Energy
- IPO targets $693.8M to scale advanced nuclear reactors and fuel, with major growth and risk.XE
Registration filing20 Apr 2026 - IPO targets $693.8M to fund advanced nuclear growth, with strong market potential and significant execution risks.XE
Registration filing15 Apr 2026 - IPO aims to fund advanced nuclear reactor and fuel commercialization amid high growth and risk.XE
Registration filing8 Apr 2026 - IPO targets SMR and fuel commercialization in a vast market, but faces high execution risk.XE
Registration filing25 Mar 2026